Aerobic capacity in adult dermatomyositis/polymyositis patients and healthy controls

Archives of Physical Medicine and Rehabilitation

Volumn 81, Issue 1, 2000, Pages 1-5

  Wiesinger, Guenther F ^a,c   Quittan, Michael ^a   Nuhr, Martin ^a   Volc Platzer, Beatrix ^a   Ebenbichler, Gerold ^a   Zehetgruber, Manfred ^a   Graninger, Winfried ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Aerobic; Dermatomyositis; Exercise; Polymyositis; Rehabilitation

Indexed keywords

CREATINE KINASE; OXYGEN;

ADULT; AEROBIC CAPACITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; ENZYME ACTIVITY; EXERCISE; FEMALE; HUMAN; MALE; MUSCLE STRENGTH; OXYGEN CONSUMPTION; POLYMYOSITIS;

EID: 0033986646     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(00)90212-0     Document Type: Article

References (47)

1. Felson DT. Choosing a core set of disease activity measures fo rheumatoid arthritis clinical trials. J Rheumatol 1993;20:53 I-4.
2. Klepper SE. Darbee J. Effgen SK. Singsen BH. Physical fitness levels in children with polyarticular juvenile rheumatoid arthritis Arthritis Care Res 1992;5:93-100.
3. Burckhardt CS. Moncur C. Minor MA. Exercise tests as outcome measures. Arthritis Care Res 1994;7: 169-75.
4. Stenström CH. Therapeutic exercise in rheumatoid arthritis. Arthritis Care Res 1994;7:190-7.
5. Semble EL. Loeser RF. Wise CM. Therapeutic exercise fo rheumatoid arthritis and osteoarthritis. Semin Arthritis Rheun 1990;20:32-40.
6. Escalante A, Miller L, Beardmore TD. Resistive exercise in the rehabilitation of polymyositis/dermatomyositis. J Rheumatol 1993 20:1340-4.
7. Hicks JE. Miller F. Plotz P. Chen TH. Gerber L. Isometric exercise increases strength and does not produce sustained creatininr phosphokinase increases in a patient with polymyositis. J Rheumatol 1993;20:1399-40 I.
8. Wiesinper GE Quittan M. Aringer M. Seeber A. Volc-Platzer B Smolen J. et al. Improvement of physical fitness and muscle strength in polymyositis/dermatomyositis patients by a physica training programme. Br J Rheumatol 1998;37: 196-200.
9. Hicks JE, Drinkard B. Jain M. Danoff J, Gerber L. Aerobic capacity in juvenile dermatomyositis (JDM) and normal juvenile subjects [abstract]. Arthritis Rheum 1997:40(9 Suppl): 140.
10. Wiesinger GF, Quittan M. Graninper M. Seeber A. Ebenbichler G Sturm B. et al. Benefit of 6 -months long-term training ir polymyositis/dermatomyositis patients. Br J Rheumetol 1998;37 i 338-42.
11. Cronin ME. Treatment. In: Plotz PH. moderator. Current concept! in the idiopathic inflammatory myopathies: polymyositis, dermato myositis and related disorders. Ann Intern Med 1989; I I I : 143-57
12. Denbow CE, Lie JT, Tancredi RG. Bunch TW. Cardiac involve ment in polymyositis: a clinicopathologic study of 20 autopsied patients. Arthritis Rheum 1979;22: 1088-92.
13. Salmeron G. Greenberg SD. Lidsky MD. Polymyositis and diffuse interstitial lung disease: a review of the pulmonary histopathologic findings. Arch Intern Med 1981:141:1005-10.
14. Haupt HM. Hutchins GM. The heart and cardiac conduction system in polymyositis-dermatomyositis: a clinicopathologic stud) of 16 autopsied patients. Am J Cardiol 1982;50:998-1006.
15. Tymms KE, Webb J. Dermatopolymyositis and other connective tissue diseases: a review of 105 cases. J Rheumatol 1985; 12 1140-8.
16. Lakhanpal S, Lie JT, Conn DL. Martin WJ. Pulmonary disease ir polymyositis/dermatomyositis: a clinicopathological analysis o 65 autopsy cases. Ann Rheum Dis 1987;46:23-9.
17. Hebert CA. Bymes TJ. Baethge BA. Wolf RE. Kinasewitz GT Exercise limitationin patients with polymyositis. Chest 1990;98 352-7.
18. Blair SN, Kohl HW, Plaffenbarger RS. How much physica activity is good for health'? Ann Rev Pub Health 1992; 13:99-126.
19. Bohan A. Peter JB. Polymyositis and dermatomyositis. N Engl . Med 1975;292:344-7, 403-7.
20. Dalakas M. Biopsy findings in skeletal muscle. In: Plotz PH moderator. Current concepts in the idiopathic inflammatory myopa thies: polymyositis. dermatomyositis and related disorders. Anr Intern Med 1989;111:143-57.
21. Lane RJ, Emslie-Smith A, Mosquera IE, Hudgson P. Clinical, biological and histological response to treatment in polymyositis. A prospective study. J R Soc Med 1989;82:333-8.
22. Mader R. Keystone EC. Inflammatory myopathy - do we have adequate measures of the treatment response. J Rheumatol 1993;20: 1105-7.
23. Dalakas MC. Polymyositis, dermatomyositis, and inclusion-body myositis. N Engl J Med 1991;325:1487-98.
24. Vignos PJ. Goldwin J. Evaluation of laboratory tests in diagnosis and management of polymyositis. Am J Med 1972;263:291-308.
25. Pennington RT. Biochemical aspects of muscle disease. In: Walton JN. editor. Disorders of voluntary muscle. New York: Churchill Livingstone; 1981. p. 415-47.
26. Kroll MA, Otis JC, Kagen LJ. Serum enzyme, myoglobin and muscle strength relationships in polymyositis and dermatomyositis. J Rheumatol 1986; 13:349-55.
27. Kagen LJ, Aram S. Creatine kinase activity inhibitor in sera from patients with muscle disease. Arthritis Rheum 1987;30:213-7.
28. Stoll T, Briihlmann P, Stucki G, Seifert B, Michel BA. Muscle strength assessment in polymyositis and dermatomyositis evaluation of the reliability and clinical use of a new, quantitative, easily applicable method. J Rheumatol 1995;22:473-7.
29. Beaver WL. Wasserman K, Whipp BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1986;60:2020-7.
30. Wasserman K, Hansen JE, Sue DY, Whipp BJ, Casaburi R. editors. Principles of exercise testing and interpretation. Philadelphia (PA): Lea and Febiger; 1994.
31. Barr AE, Kroll M. Biomechanical muscle performance. Muscle Nerve 1990;13 Suppl:21S-25S.
32. Coplan NL, Gleim GW, Nicholas JA. Exercise-related changes in serum catecholamines and potassium: effect of sustained exercise above and below lactate threshold. Am Heart J 1989;117:1070-5.
33. Haskell WL. Leon AS, Caspersen CJ, Froelicher VF, Hagberg JM, Harlan W, et al. Cardiovascular benefits and assessment of physical activity and physical fitness in adults. Med Sci Sports Exerc 1992;24 Suppl:201S-20S.
34. Howley ET. Basset DR. Welch HG. Criteria for maximal oxygen uptake: review and commentary. Med Sci Sports Exerc 1995;27: 1292-301.
35. Shephard RJ. Bouhlel E, Vandewalle H, Monod H. Muscle mass as a factor limiting physical work. J Appl Physiol 1988;64: 1472-9.
36. Fletcher GF, Froelicher VF, Hartley LH, Haskell WL, Pollock ML. Exercise standards. A statement for health professionals from the American Heart Association. Circulation 1990;82:2286-322.
37. Fleg JL, Lakatta EG. Role of muscle loss in the age-associated reduction in Vo, max. J Appl Phvsiol 1988;65: 1147-5 1.
38. Mastaglia FL. Adverse effect of drugs on muscle. Drugs 1982;24: 304-2 I.
39. Horber FF, Hoppeler H, Scheideigger JR, Grunig BE, Howald H. Impact of physical training on midthigh muscle in normal subjects and in patients with glucocorticoids. J Clin Invest 1987;79: 1181-90.
40. Hokanson JF, Mercier JG, Brooks GA. cyclosporine A decreases rat skeletal mitochondrial respiration in vitro. Am J Resp Crit Care Med 1995;151:1848-51.
41. Mercier JG, Hokanson JF, Brooks GA. Effects of cyclosporine A on skeletal muscle mitochondria and endurance time. Am J Resp Crit Care Med 1995;151:1532-36.
42. Kroll MA, Otis JC, Kagen LJ. Abnormalities in quadriceps-hamstrings strength. Relationship in polymyositis and dermatomyositis. J Rheumatol 1988;15:1782-8.
43. Josefson A, Romanus E, Carlsson J. A functional index in myositis. J Rheumatol 1996;23: 1380-4.
44. McDermott W. Absence of indicators of the influence of physicians on a society's health; impact of physician care on society. Am J Med 1981;70:833-43.
45. Tarlov AR. Shattuck lecture: the increasing supply of physicians, the changing structure of the health services system and the future practice of medicine. N Engl J Med 1983;308:1235-44.
46. Schroeder SA. Outcome assessment 70 years later. Are we ready? [editorial] N Engl J Med 1987;216:160-2.
47. Ellwood PM. Shattuck lecture: outcome management: a technology of patient experience. N Engl J Med 1988;318: 1549-56.